JERUSALEM, Nov. 13, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate in the Jefferies London Healthcare Conference.  Jefferies London Healthcare Conference Date: November 20-21, 2019Company Presentation: Wednesday, November 20, 2019 at

REHOVOT, Israel, Nov. 13, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today its financial results for the third quarter, ending September 30, 2019.

PALO ALTO, Calif., Nov. 13, 2019 /PRNewswire/ -- Preventing depression in pregnant women or in women who have recently given birth (perinatal depression) may have long-lasting impact. In the Oct. 30 issue of

– NODE-301 topline data readout expected in mid-1H20 –– Richard Pasternak, M.D. appointed to the Company's Board of Directors – MONTREAL and CHARLOTTE, N.C., Nov. 13, 2019 /PRNewswire/ -- Milestone Pharmaceuticals

ALPHARETTA, Ga., Nov. 13, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Stifel 2019 Healthcare Conference in New York City on Wednesday, Nov. 20 at approximately 8 a

INDIANAPOLIS, Nov. 13, 2019 /PRNewswire/ -- Allwell from MHS announces a partnership with the National Council on Aging (NCOA) to help prevent falls among Medicare Advantage beneficiaries.Falls are a leading cause of injury for people aged 65 and older and can threaten their safety and independence, as well as generate great economic and personal hardshi

LAS VEGAS, Nov. 13, 2019 /PRNewswire/ -- PROVE Holdings, LLC is redefining case management in the personal injury care business with its focus on strong partnerships, a patient centric approach, time-saving technology and customized financing options.The aftermath of an accident can be financially devastating for a family. PROVE works with law firms and

LAINATE, Italy, Nov. 13, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company focused on developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today that it has received approval from the German Authority BfArM and the coordinat

NESS ZIONA, Israel, Nov. 13, 2019 /PRNewswire/ --  ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor-based therapies for neurodegenerative diseases including Alzheimer's Disease, today announced the signing of a binding agreement for a $US 3.6 million equity financing round

NORTH CHICAGO, Ill., Nov. 13, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of November 11, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,830,254 shares of common stock with a par value of $0.0